ArticleFrontiers in pharmacology2022

Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trials.

Suiyuan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.